NewAmsterdam Pharma N.V. (NAMS)
23.89
0.22 (0.93%)
At close: Jan 15, 2025, 12:58 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -176.94M | -78.05M | -28.60M | -5.75M |
| Depreciation & Amortization | 49.00K | 72.00K | 14.00K | 1K |
| Stock-Based Compensation | 24.57M | 4.12M | 1.24M | n/a |
| Other Working Capital | 796.00K | 11.46M | -16.97K | -576.30K |
| Other Non-Cash Items | 5.23M | 70.57M | -7.00K | 306.00K |
| Deferred Income Tax | n/a | n/a | -1.44M | n/a |
| Change in Working Capital | 5.87M | 11.46M | 3.82M | -528.00K |
| Operating Cash Flow | -141.22M | 7.97M | -25.16M | -5.97M |
| Capital Expenditures | -24.00K | -13.00K | -20.00K | -13.00K |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 728.00K | n/a | -112.79M |
| Investing Cash Flow | -24.00K | 715.00K | -20.00K | -13.00K |
| Debt Repayment | n/a | 747.00K | n/a | 13.92M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 8.91M | -5.79M | -15.71M | -2.60M |
| Financial Cash Flow | 8.91M | 375.18M | 68.99M | 11.32M |
| Net Cash Flow | -127.28M | 385.43M | 45.23M | 5.36M |
| Free Cash Flow | -141.24M | 7.96M | -25.18M | -5.98M |